The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma

BACKGROUND: Esophageal basaloid squamous cell carcinoma (EBSCC) is a rare malignancy. Serum apolipoprotein A-I (APO A-I) has proved to be a potentially useful prognostic indicator in various cancers. However, no studies have analyzed the prognostic significance of serum APO A-I in patients with EBSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ji-Feng, Zhao, Jian-Ming, Yang, Xun, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474064/
https://www.ncbi.nlm.nih.gov/pubmed/34588815
http://dx.doi.org/10.2147/CMAR.S328138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474064/
https://www.ncbi.nlm.nih.gov/pubmed/34588815
http://dx.doi.org/10.2147/CMAR.S328138

Ejemplares similares